Dr. Yufeng Yao 姚宇锋
Chief Physician, Associate Professor
Department of Breast Surgery, Jiangsu Cancer Hospital, Nanjing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgery-based comprehensive treatment for breast cancer, including chemotherapy, endocrine therapy, and targeted therapy. Proficient in radical mastectomy, breast-conserving surgery, and reconstruction.
Dr. Yao holds a PhD and completed postdoctoral training in breast surgery. An Associate Professor at Nanjing Medical University and master’s supervisor, Dr. Yao focuses on early diagnosis, breast-conserving surgery, reconstruction, and comprehensive care. Recognized as a Jiangsu Province high-level talent, Dr. Yao received the 2015 Jiangsu Science and Technology Progress Award (Second Class) and leads or participates in multiple national and provincial research projects.
Professional roles
- Member, Committee on Precision Cancer Treatment, China Anti-Cancer Association
- Member, Case Management Committee, China Anti-Cancer Association
- Standing Committee Member, Precision Medical Branch, Chinese Geriatrics and Gerontology Society
- Youth Editorial Board Member, Chinese Journal of Cancer Prevention and Treatment
Name order: in Chinese the family name comes first (Yao Yufeng). Papers usually list the name as Yufeng Yao or Yao Y.
Selected publications
14 papers on PubMed matched by name and affiliation; 6 as first or senior author since 2016. Most recent first- or senior-author papers:
- Bioengineered, 2022 (senior author): Inhibition of endoplasmic reticulum stress alleviates triple-negative breast cancer cell viability, migration, and invasion by Syntenin/SOX4/Wnt/β-catenin pathway via regulation of heat shock protein A4. PubMed 35442158
- Am J Transl Res, 2020 (senior author): The activation of GPER inhibits cells proliferation, invasion and EMT of triple-negative breast cancer via CD151/miR-199a-3p bio-axis. PubMed 32051735
- Am J Transl Res, 2019 (senior author): Mechanism of GPER promoting proliferation, migration and invasion of triple-negative breast cancer cells through CAF. PubMed 31632554
- J Surg Res, 2019 (first author): Breast-Conserving Surgery in Patients With Mammary Paget's Disease. PubMed 31026796
- Cancer Biother Radiopharm, 2019 (senior author): Correlation Between HER-2 Gene Amplification or Protein Expression and Clinical Pathological Features of Breast Cancer. PubMed 30585768
- Exp Ther Med, 2018 (senior author): Effect of miR-146a-5p on proliferation and metastasis of triple-negative breast cancer via regulation of SOX5. PubMed 29731835
- Curr Opin Oncol, 2015 (senior author): Mechanisms of breast cancer resistance to anthracyclines or taxanes: an overview of the proposed roles of noncoding RNA. PubMed 26371779
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion